Chimeric Therapeutics is trading 25% up at A$0.01, with no specific catalyst identified.
- The move follows declines in recent sessions.
- A prior filing covered the quotation of 22,222,222 shares issued September 22, but does not establish the reason for the September 28 rise.
- The supplied market context indicates no significant broad-market move.